Clinical Trials Directory

Trials / Completed

CompletedNCT01803568

Skeletal Muscles, Myokines and Glucose Metabolism MYOGLU

Skeletal Muscles, Myokines and Glucose Metabolism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
Male
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

Normal glucose uptake and metabolism in skeletal muscles are essential to keep blood glucose within normal range and hence, insulin resistance (possibly mediated by inflammatory processes) in skeletal muscle is a major pathogenic factor in type 2 diabetes. Physical activity seems to be of essential importance in the prevention and treatment of type 2 diabetes. Myokines are proteins secreted from skeletal muscle that can execute important biological functions locally in the muscle (paracrine) or in other organs like the brain, heart and pancreas (endocrine). Evidence suggest that several interleukines and other cytokines are secreted by skeletal muscles. In the present project, the investigators will explore the relation between secreted myokines from muscle cells, insulin resistance and glucose metabolism before and after 12 weeks of exercise intervention. Subjects with normal as well as impaired glucose metabolism will be included in the study.

Conditions

Interventions

TypeNameDescription
OTHERExercise12 weeks of exercise; 4 times pr week

Timeline

Start date
2011-09-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2013-03-04
Last updated
2013-03-04

Source: ClinicalTrials.gov record NCT01803568. Inclusion in this directory is not an endorsement.